Expanding HIV testing: Back to the future

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue SUPPL. 2, 2013, Pages

  Branson, Bernard M ^a   Viall, Abigail ^a   Marum, Elizabeth ^b  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HIV antibody tests; HIV diagnosis; HIV prevention; HIV testing; Policy

Indexed keywords

ANTIVIRUS AGENT; NEVIRAPINE; ZIDOVUDINE;

AFRICA; ANTIVIRAL THERAPY; ARTICLE; AUSTRALIA; BLOOD TRANSFUSION; DIAGNOSTIC ACCURACY; DISEASE TRANSMISSION; EMERGENCY WARD; EPIDEMIC; FOLLOW UP; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; KENYA; PREGNANT WOMAN; PRIORITY JOURNAL; SCALE UP; UNITED STATES; WORLD HEALTH ORGANIZATION;

ANTI-RETROVIRAL AGENTS; EARLY DIAGNOSIS; FORECASTING; HIV INFECTIONS; HUMANS; MASS SCREENING;

EID: 84880207457     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182986f25     Document Type: Article

References (72)

1. WHO. Global health sector strategy on HIV/AIDS 2011-2015. 2011. Available at: http://whqlibdoc.who.int/publications/2011/9789241501651-eng. pdf. Accessed February 14, 2013.
2. Marks G, Crepaz N, Senterfitt JW, et al. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. J Acquir Immune Defic Syndr. 2005;39:446-452.
3. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
4. Granich RM, Gilks CF, Dye C, et al,. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48-57.
5. Ruark A, Shelton JD, Halperin DT, et al,. Universal voluntary HIV testing and immediate antiretroviral therapy. Lancet. 2009;373:1078; author reply 1080-1071.
6. Lackritz EM, Satten GA, Aberle-Grasse J, et al. Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States. N Engl J Med. 1995;333:1721-1725.
7. Meyer KB, Pauker SG. Screening for HIV: can we afford the false positive rate? N Engl J Med. 1987;317:238-241.
8. Rhame FS, Maki DG. The case for wider use of testing for HIV infection. N Engl J Med. 1989;320:1248-1254.
9. Piot P. No Time to Lose: A Life in Pursuit of Deadly Viruses. New York, NY: W.W. Norton & Co; 2012.
10. Higgins DL, Galavotti C, O'Reilly KR, et al. Evidence for the effects of HIV antibody counseling and testing on risk behaviors. JAMA. 1991;266: 2419-2429.
11. Doll LS, Kennedy MB. HIV counseling and testing: what is it and how well does it work? In: Schochetman G, George JR, eds. AIDS Testing: A Comprehensive Guide to Technical, Medical, Social, Legal, and Management Issues. 2nd ed. New York, NY: Springer-Verlag;1994:302-319.
12. CDC. Public Health Service guidelines for counseling and antibody testing to prevent HIV infection and AIDS. MMWR Morb Mortal Wkly Rep. 1987;36:509-515.
13. Lackritz EM. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges. AIDS. 1998; 12(suppl A):S81-S86.
14. deCock KM, Mbori-Ngacha D, Marum E. Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century. Lancet. 2006;360:67-72.
15. Rutherford GW, Lifson AR, Hessol NA, et al. Course of HIV-I infection in a cohort of homosexual and bisexual men: an 11 year follow up study. BMJ. 1990;301:1183-1188.
16. Hearst N, Hulley SB. Preventing the heterosexual spread of AIDS. Are we giving our patients the best advice? JAMA. 1988;259:2428-2432.
17. Connor EM, Sperling RS, Gelber R, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med. 1994;331:1173-1180.
18. Downing R, Otten R, Marum E. Optimizing the delivery of HIV counseling and testing services: the Uganda experience using rapid HIV antibody test algorithms. J Acquir Immune Defic Syndr. 1998;18:384-388.
19. Kassler W, Alwano-Edyegu M, Marum E. Rapid HIV testing with same-day results: a field trial in Uganda. Int J STD AIDS. 1998;9:134-138.
20. Kassler W, Dillon B, Haley C. On-site, rapid HIV testing with same-day results and counseling. AIDS. 1997;11:1045-1051.
21. CDC. U.S. Public Health Service recommendations for human immunodeficiency virus counseling and voluntary testing for pregnant women. MMWR Recomm Rep. 1995;44:1-15.
22. Cartoux M, Meda N, Van de Perre P, et al. Acceptability of voluntary HIV testing by pregnant women in developing countries: an international survey. Ghent International Working Group on Mother-to-Child Transmission of HIV. AIDS. 1998;12:2489-2493.
23. Simpson WM, Johnstone FD, Goldberg DJ, et al. Antenatal HIV testing: assessment of a routine voluntary approach. BMJ. 1999;318:1660-1661.
24. Anderson JE, Santelli J, Mugalla C. Changes in HIV-related preventive behavior in the US population: data from national surveys, 1987-2002. J Acquir Immune Defic Syndr. 2003;34:195-202.
25. Marum E, Taegtmeyer M, Parekh B, et al. "What took you so long?" The impact of PEPFAR on the expansion of HIV testing and counseling services in Africa. J Acquir Immune Defic Syndr. 2012;60(suppl 3):S63-S69.
26. WHO, UNAIDS. The importance of simple/rapid assays in HIV testing. Wkly Epidemiol Rec. 1998; 73: 321-328.
27. CDC. Approval of a new rapid test for HIV antibody. MMWR Morb Mortal Wkly Rep. 2002;51:1051-1052.
28. Media Release. Rapid HIV test approved in Australia. 2012. Available at: http://www.health.gov.au/internet/ministers/publishing.nsf/Content/ mr-yr12-ck-ck060.htm. Accessed February 12, 2013.
29. McKenna SL, Muyinda GK, Roth D, et al. Rapid HIV testing and counseling for voluntary testing centers in Africa. AIDS. 1997;11(suppl 1):S103-S110.
30. Grabbe KL, Menzies N, Taegtmeyer M, et al. Increasing access to HIV counseling and testing through mobile services in Kenya: strategies, utilization, and cost-effectiveness. J Acquir Immune Defic Syndr. 2010;54:317-323.
31. Marum E, Taegtmeyer M, Chebet K. Scale-up of voluntary HIV counseling and testing in Kenya. JAMA. 2006;296:859-862.
32. Emery S, Neuhaus JA, Phillips AN, et al. Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. J Infect Dis. 2008;197:1133-1144.
33. UNAIDS. UNAIDS world AIDS day report-2012. 2012. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/epide-miology/ 2012/gr2012/JC2434-WorldAIDSday-results-en.pdf. Accessed February 18, 2013.
34. CDC. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data-United States and 6 U.S. dependent areas- 2010. HIV Surveillance Supplemental Report 2012. 2012;17( No. 3 Part App. 1-27). Available at: http://www.cdc.gov/hiv/surveillance/resources/reports/2010supp-vol17no3/ pdf/hssr-vol-17-no-3.pdf. Accessed February 12, 2013.
35. Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006;296:782-793.
36. Hogan CM, Degruttola V, Sun X, et al. The setpoint study (ACTG A5217): effect of immediate versus deferred antiretroviral therapy on virologic set point in recently HIV-1-infected individuals. J Infect Dis. 2012;205:87-96.
37. Weiser SD, Heisler M, Leiter K, et al. Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns. PLoS Med. 2006;3:e261.
38. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep. 2006;55:1-17.
39. CDC. Results of the expanded HIV testing initiative-25 jurisdictions, United States, 2007-2010. MMWR Morb Mortal Wkly Rep. 2011;60: 805-810.
40. WHO. Guidance on provider-initiated HIV testing and counselling in health facilities. 2007. Available at: http://www.who.int/hiv/pub/vct/pit-c2007/en/. Accessed February 13, 2013.
41. Shanks L, Klarkowski D, O'Brien DP. False positive HIV diagnoses in resource limited settings: operational lessons learned for HIV programmes. PLoS One. 2013;8:e59906.
42. Mermin J, Cheever L. CDC-HRSA Dear colleague letter. 2013. Available at: http://nchhstp/dhap/pubs/DCL-HIV-Testing-25Feb2013-acc.pdf. Accessed March 15, 2013.
43. Tarantola D, Gruskin S. New guidance on recommended HIV testing and counselling. Lancet. 2007;370:202-203.
44. World Health Organization. Increasing access to knowledge of HIV status: conclusions of a WHO consultation, December 3-4, 2001. Available at: www.who.int/hiv/pub/vct/pub16/en/index.html. Accessed February 12, 2013.
45. Bayer R, Edington C. HIV testing, human rights, and global AIDS policy: exceptionalism and its discontents. J Health Polit Policy Law. 2009; 34:301-323.
46. Frieden TR, Das-Douglas M, Kellerman SE, et al. Applying public health principles to the HIV epidemic. N Engl J Med. 2005;353:2397-2402.
47. Manavi K, Welsby PD. HIV testing. BMJ. 2005;330:492-493.
48. CDC. HIV testing trends in the United States, 2000-2011. 2013. Available at: http://www.cdc.gov/hiv/topics/testing/resources/reports/pdf/Testing% 20Trends-cleared-01282013.pdf. Accessed February 12, 2013.
49. Lyss SB, Branson BM, Kroc KA, et al. Detecting unsuspected HIV infection with a rapid whole-blood HIV test in an urban emergency department. J Acquir Immune Defic Syndr. 2007;44:435-442.
50. White DA, Scribner AN, Schulden JD, et al. Results of a rapid HIV screening and diagnostic testing program in an urban emergency department. Ann Emerg Med. 2009;54:56-64.
51. Sattin RW, Wilde JA, Freeman AE, et al. Rapid HIV testing in a southeastern emergency department serving a semiurban-semirural adolescent and adult population. Ann Emerg Med. 2011;58(suppl 1):S60-S64.
52. Rothman RE, Hsieh YH, Harvey L, et al. 2009 US emergency department HIV testing practices. Ann Emerg Med. 2011;58(suppl 1):S3-S9e1-e4.
53. Hoover JB, Tao G, Heffelfinger JD. Monitoring HIV testing at visits to emergency departments in the United States: very-low rate of HIV testing. J Acquir Immune Defic Syndr. 2013;62:90-94.
54. Cleary PD, Barry MJ, Mayer KH, et al. Compulsory premarital screening for the human immunodeficiency virus. Technical and public health considerations. JAMA. 1987;258:1757-1762.
55. Meadows J, Irving G, Chapman K, et al. Preoperative HIV antibody testing: the views of surgeons and patients. Int J STD AIDS. 1995;6:426-430.
56. Gordin FM, Gibert C, Hawley HP, et al. Prevalence of human immunodeficiency virus and hepatitis B virus in unselected hospital admissions: implications for mandatory testing and universal precautions. J Infect Dis. 1990;161:14-17.
57. Voetsch AC, Heffelfinger JD, Yonek J, et al. HIV screening practices in U.S. hospitals, 2009-2010. Public Health Rep. 2012;127:524-531.
58. Czarnogorski M, Halloran J, Pedati C, et al. Expanded HIV testing in the United States Department of Veterans Affairs, 2009 to 2011. Am J Public Health. In press.
59. National AIDS and STD Control Programme. Guidelines for HIV Testing in Clinical Settings. Nariobi, Kenya: Ministry of Health, Republic of Kenya; 2004.
60. Chersich MF, Luchters SM, Othigo MJ, et al. HIV testing and counselling for women attending child health clinics: an opportunity for entry to prevent mother-to-child transmission and HIV treatment. Int J STD AIDS. 2008;19:42-46.
61. Huerga H, Spillane H, Guerrero W, et al. Impact of introducing human immunodeficiency virus testing, treatment and care in a tuberculosis clinic in rural Kenya. Int J Tuberc Lung Dis. 2010;14:611-615.
62. National AIDS and STD Control Programme. Guidelines for HIV Testing and Counseling in Kenya. Nairobi, Kenya: Ministry of Health, Republic of Kenya; 2010. Available at: http://nascop.or.ke/library/HTC/National%20Guidelines% 20for%20HTC%20in%20Kenya%202010.pdf. Accessed February 15, 2013.
63. Kelley AL, Karita E, Sullivan PS, et al. Knowledge and perceptions of couples' voluntary counseling and testing in urban Rwanda and Zambia: a cross-sectional household survey. PLoS One. 2011;6:e19573.
64. Wagenaar BH, Christiansen-Lindquist L, Khosropour C, et al. Willingness of US men who have sex with men (MSM) to participate in Couples HIV Voluntary Counseling and Testing (CVCT). PLoS One. 2012;7: e42953.
65. Sabapathy K, Van den Bergh R, Fidler S, et al. Uptake of home-based voluntary HIV testing in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med. 2012;9:e1001351.
66. Branson BM. Home sample collection tests for HIV infection. JAMA. 1998;280:1699-1701.
67. Myers JE, El-Sadr WM, Zerbe A, et al. Rapid HIV self-testing: long in coming but opportunities beckon. AIDS. 2013;27. [Epub ahead of print] DOI: 10.1097/QAD.0b013e32835fd7a0.
68. Carballo-Dieguez A, Frasca T, Dolezal C, et al. Will gay and bisexually active men at high risk of infection use over-the-counter rapid HIV tests to screen sexual partners? J Sex Res. 2012;49:379-387.
69. Choko AT, Desmond N, Webb EL, et al. The uptake and accuracy of oral kits for HIV self-testing in high HIV prevalence setting: a cross-sectional feasibility study in Blantyre, Malawi. PLoS Med. 2011;8:e1001102.
70. Ng OT, Chow A, Lee V, et al. Accuracy and user-acceptability of HIV self-testing using an oral fluid HIV rapid test [Abstract 1075]. 18th Conference on Retroviruses and Opportunistic Infections; 2011; Boston, Massachusetts.
71. WHO. Service delivery approaches to HIV testing and counselling (HTC): a strategic policy framework. 2012. Available at: http://www.who.int/hiv/pub/vct/ htc-framework/en/index.html. Accessed February 19, 2013.
72. Foege W. House on Fire: The Fight to Eradicate Smallpox. Berkely, CA: University of California Press; 2011.